Anti‐erbB receptor strategy as a gene therapeutic intervention to improve radiotherapy in malignant human tumours

References

• AMORINO, G. P., HAMILTON, V. M., VALERIE, K., DENT, P., LAmmERIN GG. and SCHMIDT-ULLRICH, R. K., 2002, Epidermal growth factor receptor dependence of radiation-induced transcription factor activation in human breast carcinoma cells. Molecular Biology of the Cell, 13, 2233–2244.
   Google Scholar
• BOWERS, G., REARDON, D., HEwn, T. H., DENT, P., MIKKELSEN, R. B., VALERIE, K., LAMMERING, G., Alum, C. and SCHMIDT-ULLRICH, R. K., 2001, The relative role of ErbB1-4 receptor tyrosine kinase in radiation signal transduction responses ofhuman carcinoma cells. Oncogene, 20, 1388–1397.
   Google Scholar
• BROWN, J. M. and LEMMON, M. J., 1990, Potentiation by the hypoxic cytotoxin SR 4233 of cell killing produced by fractionated irradiation of mouse tumour. Cancer Research, 50, 7745–7749.
   PubMed Web of Science ®Google Scholar
• BRUST, D., FEDEN, J., FARNSWORTH, J., AMIR, C., BROADDUS, W. C. and VALERIE, K., 2000, Radiosensitization of rat glioma with bromodeoxycytidine and adenovirus expressing herpes simplex virus-thymidine kinase delivered by slow, rate-controlled positive pressure infusion. Cancer Gene Therapy, 7, 778–788.
   PubMed Web of Science ®Google Scholar
• CARTER, S., AUER, K. L., BIRRER, M., FISHER, P. B., SCHMIDT-ULLRICH, R. K., VALERIE, K., MIKKELSEN, R. and DENT, P., 1998, Inhibition of the mitogen activated protein (MAP) kinase cascade potentiates cell killing by low dose ionizing radiation in A431 human squamous carcinoma cells. Oncogene, 16, 2787–2796.
   Google Scholar
• CONTESSA, J. N., HAMPTON, J., LAMMERING, G., MIKKELSEN, R. B., DENT, P., VALERIE, K. and SCHMIDT-ULLRICH, R. K., 2002, Ionizing radiation activates Erb-B receptor dependent Akt and p70 S6 kinase signaling in carcinoma cells. Oncogene, 21, 4032–4041.
   Google Scholar
• CONTESSA, J. N., REARDON, D. B., TODD, D., DENT, P., MIKKELSEN, R. B., VALERIE, K., BOWERS, G. D. and SCHMIDT-ULLRICH, R. K., 1999, The inducible expression of dominant negative epidermal growth factor receptor CD533 results in radiosensitization of human mammary carcinoma cells. Clinical Cancer Research, 5, 405–411.
   Google Scholar
• FERTIL, B., DERTINGER, H., Comm', A. and MALAISE, E. P., 1984, Mean inactivation dose: a useful concept for intercom-parison of human cell survival curves. Radiation Research, 99, 73–84.
   Google Scholar
• GOLDKORN, T., BALABAN, N., SHANNON, M. and MATSUKUMA, K., 1997, EGF receptor phosphorylation is affected by ionizing radiation. Biochemica et Biophysica Acta, 1358, 289–299.
   PubMed Web of Science ®Google Scholar
• GULLIFORD, T. J., HUANG, G. C., OUZANG, X. and EPSTEIN, R. J., 1997, Reduced ability of transforming growth factor-alpha to induce EGF receptor heterodimerization and down-regulation suggests a mechanism of oncogenic synergy with ErbB2. Oncogene, 15, 2219–2223.
   PubMed Web of Science ®Google Scholar
• HAHN, G. M. and LniTE, J. B., 1972, Plateau-phase cultures of mammalian cells: an in vitro model for human cancer. Current Topics in Radiation Research Quarterly, 8, 39–83.
   PubMedGoogle Scholar
• HARARI, P. M. and HUANG, S. M., 2001, Radiation Response modification following molecular inhibition of epidermal growth factor receptor signaling. Seminars in Radiation Oncology, 12, 21–26.
   Google Scholar
• Ho, K. C. and LIN, P. S., 1997, Safranin 0 counterstaining enhances the counting of fl-galactosidase-expressing cells. Biotechniques, 23, 642.
   PubMed Web of Science ®Google Scholar
• KASHLES, 0., YARDEN, Y., FISHER, R., ULLRICH, A. and SCHLESSINGER, J., 1991, A dominant negative mutation suppresses the function of normal epidermal growth factor receptors by heterodimerization. Molecular and Cell Biology, 11, 1454–1463.
   Google Scholar
• KAVANAGH, B. D., LIN, P. S., CHEN, P. and SCHMIDT-ULLRICH, R. K., 1995, Radiation-induced enhanced proliferation of human squamous cancer cells in vitro: a release from inhibition by epidermal growth factor. Clinical Cancer Research, 1, 1557–1562.
   Google Scholar
• LAmmERING, G., HEwn, T. H., HAWKINS, W. T., CONTESSA, J. N., REARDON, D. B., LIN, P. S., VALERIE, K., DENT, P., MIKKELSEN, R. B. and Saaffur-UmucH, R. K., 2001b, Epidermal growth factor receptor as a genetic therapy target for carcinoma cell radiosensitization. Journal of the National Cancer Institute, 93, 921–929.
   Google Scholar
• LAMIVIERING, G., LIN, P. S., CONTESSA, J. N., HAMPTON, J., VALERIE, K. and SCHMIDT-ULLRICH, R. K., 2001c, Adenovirus-mediated over-expression of dominant negative epidermal growth factor receptor-CD533 as a gene therapeutic approach radiosensitizes human carcinoma and malignant glioma cells. International Journal of Radiation Oncology, Biology and Physics, 51, 775–784.
   Google Scholar
• LAM MERING, G., VALERIE, K., LIN, P. S., MIKKELSEN, R. B., CONTESSA, J. N., FEDEN, J. P., FARNSWORTH, J., DENT, P. and Sumscur-UmucH, R. K., 2001a, Radiosensitization of malig-nant glioma cells through over-expression of dominant-negative EGFR. Clinical Cancer Research, 7, 682–690.
   Google Scholar
• NASU, S., MG, K. K., FAN, Z. and MrLAs, L., 2001, C225 antiepidermal growth factor receptor antibody enhances tumour radiocurability. International Journal of Radiation Oncology, Biology and Physics, 51, 474–477.
   PubMed Web of Science ®Google Scholar
• PARK, J. S., CARTER, S., REARDON, D. B., SCHMIDT-ULLRICH, R., DENT, P. and FISHER, P. B., 1999, Roles for basal and stimulated p21 (Cip-1/WAF1/MDA6) expression and mitogen-activated protein kinase signaling in radiation-induced cell cycle checkpoint control in carcinoma cells. Molecular Biology of the Cell, 10, 4231–4246.
   Google Scholar
• REARDON, D. R., CONTESSA, J. N., MIKKELSEN, R. B., VALEIUE, K., AMIR, C., DENT, P. and SCHMIDT-ULLRICH, R. K., 1999, Dominant negative EGFR-CD533 and inhibition of MAPK modify JNK1 activation and enhance radiation toxicity of human mammary carcinoma cells. Oncogene, 18, 4756–4766.
   Google Scholar
• SCHMIDT-ULLRICH, R. K., CONTESSA, J. N., DENT, P., MIKKELSEN, R. B., VALERIE, K. and REARDON, D. B., 1999, Molecular mechanisms of radiation-induced accelerated repopu-lation. Radiation Oncology Investigations, 7, 321–330.
   Google Scholar
• SCHMIDT-ULLRICH, R. K., DENT, P., GRANT, S., MIKKELSEN, R. B. and VALERIE, K., 2000, Signal transduction and cellular radiation responses. Radiation Research, 153, 245–257.
   Google Scholar
• SCHMIDT-ULLRICH, R. K., VALERIE, K., FOGLEMAN, P. B. and WALTERS, J. M., 1996, Radiation-induced auto-phosphorylation of epidermal growth factor receptor in human malignant mammary and squamous epithelial cells. Radiation Research, 145, 79–83.
   Google Scholar
• VALERIE, K., 1999, Viral vectors for gene therapy. In S. Wu-Pong and Y. Rojanasakul (eds), Biopharmaceutical Drug Design and Development (Totowa: Humana).
   Google Scholar
• VALERIE, K., BRUST, D., FARNSWORTH, J., AMIR, C., TAHER, M., HERSHEY, C. and FEDEN, J., 2000, Improved radio-sensitization of rat glioma cells with adenovirus-expressed mutant HSV-TK in combination with acyclovir. Cancer Gene Therapy, 7, 879–884.
   PubMed Web of Science ®Google Scholar